Clinical Research Directory
Browse clinical research sites, groups, and studies.
TRAP Study: Testosterone for Androgen Receptor Polymorphism
Sponsor: Instituto Bernabeu
Summary
To determine whether pretreatment with transdermal testosterone increases the number of cumulus-oocyte complexes (COCs) obtained after ovarian stimulation by more than 1.5 in patients with low ovarian reserve and androgen receptor polymorphism undergoing intracytoplasmic sperm injection (ICSI).
Official title: Transdermal Testosterone Pretreatment in Poor Responders With Androgen Receptor Polymorphism Undergoing ICSI: A Randomized Clinical Investigation.
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-09-30
Completion Date
2026-12-31
Last Updated
2025-05-09
Healthy Volunteers
Yes
Conditions
Interventions
Transdermal Gel in Sachet Dosage Form
Transdermal testosterone gel application prior to ovarian stimulation in the study group.
No pretreatment
No pretreatment prior to the ovarian stimulation in the control group.
Locations (1)
Instituto Bernabeu
Alicante, Alicante, Spain